Logo

DISCLAIMER

KATSULA PHARMA is a Securities Market Maker(DSMM) in the parallel pharmaceutical market.
These are currently with a refused market authorization status. Our main objective is to bring back to the secondary pharmaceutical market new medications, APIs and FDCs that have an status not approved for human use or have no medicinal value according to EMA Scientific Committees.

Our financial securities are backed by the following:

IMPORTANT References to APIs or pharmaceutical terms are for classification only and don’t imply any approved medical use or safety.

What can you do?

Through further continued access to katsulapharma, you are accepting and acknowledging to clearly follow the previous rules conveyed, you affirm your understanding and acceptance of these conditions, including accessing and utilizing the services avaible via katsulapharma.com/indexema.html in case you are part of any EMA regulatory bodies, and understand that if reasonably suspect failure to meet this basic condition, KATSULA PHARMA reserves the right at it's own discretion to entirely terminate your access to our market.

Contacts